Real-world efficacy of deep TMS for obsessive-compulsive disorder: interim post-marketing analysis of 192 patients from twenty-two sites

• Geoffrey Grammer,
• Aron Tendler,
• Mehmet Kemal Arikan,
• Ryan Vidrine,
• David Kent,
• Owen Muir,
• Carlene MacMillan,
• Leah Casuto,
• William Sauve,
• Kellie Tolin,
• Steven A. Harvey,
• Misty Borst,
• Robert Rifkin,
• Manish Sheth,
• Brandon Cornejo,
• Raul Rodriguez,
• Saad Shakir,
• Taylor Porter,
• Deborah Kim,
• Brent Peterson,
• Julia Swofford,
• Brendan Roe,
• Rebecca Sinclair,
• Tal Harmelech,
• Abraham Zangen,
• Yiftach Roth

Affiliations

Geoffrey Grammer

Greenbrook Neurohealth

Aron Tendler

BrainsWay; Ben Gurion University of the Negev Department of Life Sciences; Advanced Mental Health Care Inc; Corresponding Author.

Mehmet Kemal Arikan

Akademik Psychiatry and Psychotherapy Center

Ryan Vidrine

TMS Health Solutions

David Kent

NuMe TMS

Owen Muir

Brooklyn Minds

Carlene MacMillan

Brooklyn Minds

Leah Casuto

Lindner Center of Hope Department of Psychiatry & Behavioral Neuroscience University of Cincinnati College of Medicine Cincinnati Children’s Hospital Medical Center

William Sauve

Greenbrook Neurohealth

Kellie Tolin

Greenbrook Neurohealth

Steven A. Harvey

Greenbrook Neurohealth

Misty Borst

Greenbrook Neurohealth

Robert Rifkin

Greenbrook Neurohealth

Manish Sheth

Greenbrook Neurohealth

Brandon Cornejo

Greenbrook Neurohealth

Raul Rodriguez

Delray Center for Healing

Saad Shakir

Silicon Valley TMS

Taylor Porter

Prime TMS

Deborah Kim

Mainline TMS

Brent Peterson

The Family Living Institute

Julia Swofford

TMS NW

Brendan Roe

TMS NW

Rebecca Sinclair

Brooklyn Minds

Tal Harmelech

BrainsWay

Abraham Zangen

BrainsWay; Ben Gurion University of the Negev Department of Life Sciences

Yiftach Roth

BrainsWay; Ben Gurion University of the Negev Department of Life Sciences